Life Science Hotlist

Find selected Life Science companies in Stockholm

The Stockholm-Uppsala Life Science Investment Hotlist features a carefully selected list of investment cases from one of the world’s leading knowledge regions. Curated by Invest Stockholm , the list is a tool for investors focused on disruptive commercial innovation in life science. The hotlist is updated continuously so stay tuned. This project is supported by the European Union.

Please contact us to book a meeting free of charge, to nominate a company to the hotlist or to request a full version (pdf) of the hotlist. 

Category
Sub Category
  • Abera Bioscience - has developed next-generation bacterial and derived OMV vaccine delivery platforms that combine high-level multivalent antigen presentation with strong stimulation of the immune system.

  • Affibody - is a clinical stage biopharmaceutical company developing a portfolio of innovative drug projects based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

  • Alteruna - developing software to train health care professionals in virtual reality.

  • AlzeCure Pharma - Develops innovative therapies for the treatment of Alzheimer ́s disease and related disorders.

  • Athera - is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs for treatment of cardiovascular disease.

  • Belly Balance - The digital IBS-treatment in your pocket.

  • BioLamina - Stem cell culturing made easy.

  • Biomedical Bonding - A paradigm shift in bone fracture fixation and restoration.

  • Biovica - Blood Assays for prognosis and monitoring of solid tumors.

  • BlueCall - A digital platform for anonymous therapy counseling, preventing mental health issues in collaboration with employers, insurance companies and health care providers.

  • Bonzun - offers pregnant women and expecting fathers high quality medical information in AI enhanced app, digital health for pregnant women and families.

  • Brighter - Brighter delivers data-driven solutions for smarter treatment of chronic conditions – improving quality of life, easing the burden on healthcare systems and opening new opportunities for data-driven research.

  • Byon8 - developes a Personal A.I Doctor called AITOPYA – an app that empowers patients by identifying possible diseases based on their own health data input. It provides the user with self-care recommendations and even connects them with health professionals if needed.

  • Camanio Care - a care tech company that develops innovative solutions for an excellent care at home with the individual in focus. Camanio Care offers digital service platforms for digital care, robotics, assistive devices and gamification

  • CareLigo - CareLigo’s home-based mHealth-solution OPTILOGG® is clinically proven to reduce the burden of heart failure by 29 %, and heart failure is the most common cause of hospitalization for people over 65 with 38 million people affected world wide. Having established presence on the Swedish market, the target is now set on internationalization.

  • Cartana - enables researchers from academia and industry to decipher function and disease of the brain and other organs or tumors to much greater depth than previously possible. CARTANA aims to become the number-1-facilitator for finding and validating new treatment strategies against the major diseases.

  • Coala - Coala Life has developed and launched prize-winning, digital solutions enabling daily monitoring and analysis of your heart

  • C-Sense - is a company offering intelligent sensors for a variety of applications. C-sense has developed C-nose, a multi-sensor electronic nose that can be used as a bomb-nose as well as in food control and medical diagnostics.

  • CytaCoat - provides a unique, universal and covalently coupled antibacterial coating for prevention of hospital acquired infections associated with the use of medical devices. The CytaCoat technology is active against several clinically relevant bacterial strains including multi drug resistant bacteria such as MRSA and ESBL.

  • Diamyd Medical - develops therapies using our in-licensed substances GAD and GABA for the prevention or treatment of diabetes and other serious inflammatory diseases.

  • Double Bond Pharmaceutical - develops superior medicines by formulating the best known pharmaceutical compounds to target exactly the diseased organs.

  • DoubleStrand Bioinformatic - is a full service data science and bioinformatics company providing tailored solutions to the Biotech, Healthtech, Medtech and Pharma community. We create value from your data.

  • Empe diagnostics - develops diagnostic kits which are inexpensive, easy-to-use, and provides reliable answers (tuberculosis bacteria and its resistance genotype) within two hours. As a result, doctors can immediately select the appropriate drugs enabling effective antibiotic treatment from the first clinical meeting.

  • Empros Pharma - develops EMP16 an oral treatment for obesity. Phase 2a trial demonstrates best-in-class safety profile and promising efficacy. Proof of concept trial planned for 2020. Uniquely fast moving, low cost, low risk obesity project invites professional investors.

  • Encare - enabling ERAS® (Enhanced Recovery After Surgery) for improved quality of care resulting in enhanced patient outcome and more effective healthcare spend.

  • Geras Solution - offers a digital ecosystem of clinically validated tools for individuals impacted with dementia, by providing remote access to specialists for early assessment, risk reduction and disease management support.

  • Glucox Biotech - Identifies and develops selective and specific Nox4 inhibitors with drug like properties.

  • Gradientech - ultra-rapid sepsis treatment diagnosis - The QuickMIC™ diagnostic system under development generates phenotypic antibiotic susceptibility testing (AST) results from positive blood culture in as short as 2 hours compared to 1-2 days in clinics today.

  • HepaPredict - is a contract research organization (CRO) specializing in drug metabolism and toxicity. We offer in-house evaluations of drug metabolism, pharmacokinetic properties and safety as well as drug target validations based on our novel long-term stable physiological 3D spheroid culture platform.

  • HNRY - improves health care efficiency and patient safety by automating and standardizing medical documentation. This saves time, improves quality and is cost efficient.

  • iCellate - can detect cancer before symptoms occus. It is achieved by capturing the single cells that spread the disease, the Circulating Tumor Cells (CTC).

  • InDex Pharmaceuticals - is a biopharmaceuticals company developing cobitolimod which is in late stage clinical development for ulcerative colitis with a novel mechanism of action that has shown clinical proof of concept, and is safe and well tolerated.

  • Inhalation Sciences Sweden AB - offers solutions to minimize risk and ensure success in the development of inhaled new and generic drugs. The solution saves time, weed out failures and help identify the best candidates/formulations early and cost-effectively by offering data for true in vitro- in vivo correlation (IVIVC): it gives support during the preclinical phase and potentially all the way into phase I/First-in-man testing.

  • Invicta Medical - is a medical technology company that specializes in innovative therapies for sleep apnea.

  • Lexplore - is an innovative and time efficient reading assessment tool used by teachers. Combining eye-tracking and machine learning, in just 2 minutes a student’s reading ability is analysed.

  • Linkura - Listen to your heart – Linkura prevents stress related disease using ECG wearables and online coaching.

  • Lokon Pharma - developing immunostimulatory gene therapy for cancer using oncolytic viruses.

  • MediCheck - provides people with a shortcut to medical specialists, making better use of society’s medical knowledge and delivering it to more people in need.

  • MediTuner - has developed, AsthmaTuner, the only certified self-treatment app for asthma that provides patients with instant and individualized treatment recommendations.

  • MedUniverse - is a patient case engagement platform offered to the life science industry as cloud-based SaaS, to effectively inform, educate and engage health care professionals about new treatments, therapies, guidelines and devices via digital patient cases and similar content. Aggregated anonymized data from interactions is captured which serves as valuable BI/customer insights presented in visually compelling dashboards with the possibility for further data mining/analysis.

  • Mimerse - creates evidence based automatic psychological treatments in collaboration with leading researchers and hospitals. They are on a mission to solve the world's mental health problem with immersive technologies.

  • Minnity - The Minnity app enables professional caregivers to deliver individualized dementia care to every caretaker with the help of a smartphone.

  • Neodynamics - is a new technology micropulse biopsy system for improved diagnosis of cancer patients.

  • NextCell Pharma - Is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for autoimmune and inflammatory diseases and transplantation. Drug candidate ProTrans, is a stem cell product based on mesenchymal stem cells from umbilical cord tissue with regenerative and immunosuppressive activity

  • Pelago Bioscience - is established to accelerate the use and benefits of the patented CETSA® method in Drug Discovery and Development. Our focus is to deliver physiologically relevant high quality Target Engagement data to customers and collaborators enabling them to develop better and more efficacious new drugs faster.

  • Pilloxa - develops a patient-centric adherence platform. We are currently launching our first product in the form of a smart pillbox with a connected mobile application in order to facilitate medication for the smartphone generation.

  • Prosilico - has developed unique in-silico prediction methodology for ADME/pharmacokinetics (ADME/PK), exposures, doses and optimization of candidate drugs in humans.

    Prosilico’s methods, including new software, have outperformed lab methods in several internal and external test and placed the company as world-leaders in the field. The superior accuracy and range of this validated computer-based methodology enables reliable predictions at the drug design stage and a reduction of lab studies, uncertainty, time and costs.

    Go to website
  • Qinematic - suite of software enabling an off-the-shelf sensor to record human movement in 3D. Posture, movement and balance is measured and reported electronically for the detection and prevention of injury and pain. Scan library is the basis for an AI decisions support platform.

  • Scandinavian Biopharma - is a Swedish research-based biotech company specialist in marketing and sales of specialty biopharma products in Europe.

    Research and development is mainly focused on development of the first vaccine in the world for protection against diarrhoea caused by ETEC in both travellers and endemic populations.

    Go to website
  • Sigrid Therapeutics - has developed a breakthrough medical device, SiPore15, for the treatment of cardiovascular and metabolic risk factors such as elevated blood sugar and blood fat in prediabetic and type 2 diabetic patients.

  • Sinfonia Biotherapeutics - precision therapies for genetically-defined dementia and related neurodegenerative diseases.

  • Single Technologies - develops a technology concept that enables high-resolution 3D videos of molecules, living cells and tissue for proteomic and genetic applications.

  • SinSa Labs - bioengineering Superdrugs against Superbugs.

  • Spit Lab - the mission is to help women with PCOS have healthier pregnancies through predictive analytics.

  • Sprint Bioscience - develops innovative oncology drugs. We focus on three areas that partially overlap; tumor metabolism, immune-oncology, and factors affecting the microenvironment of the tumor.

    All projects hold a high degree of innovation, where our excellence in drug development is matched with new innovative target proteins and the ambition that every product should be first and best in class as it enters the market. We have a process to develop projects from the idea stage to drug candidates in a timely and cost-effective way and have a clear medical and commercial focus, key factors for evaluating project selection.

    Go to website
  • Stardots - Stardots develops a revolutionary digital health platform for the Parkinson´s disease. It is a Software-as-a-Drug for the Symptom Quantification, Treatment Optimization and Clinical Trial aid to increase quality of life and reduce cost to society.

    More About Stardots

    Target market

    Product/Business idea

    Product development and expansion

    Go to website
  • Svenska Vaccinfabriken Produktion - develop vaccines and immunotherapies to prevent and treat chronic infections and cancers. The first candidate aims to cure hepatitis B and D and prevent cancer caused by the infection.

  • Symcel - Measure life and death of cells and bacteria through direct metabolic readout in label free cell based assays´.

  • XSpray - utilizes its innovative patented RightSize technology to develop improved and generic fully amorphous versions of marketed cancer drugs, primarily protein kinase inhibitors (PKIs) for treatment of cancer.